We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$41.1B
AUM Growth
+$5.37B
Cap. Flow
+$2.44B
Cap. Flow %
5.94%
Top 10 Hldgs %
24.49%
Holding
1,526
New
158
Increased
755
Reduced
338
Closed
110

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$170M
2
TSLA icon
Tesla
TSLA
+$155M
3
NVDA icon
NVIDIA
NVDA
+$116M
4
TSM icon
TSMC
TSM
+$87.6M
5
NTR icon
Nutrien
NTR
+$86.2M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$150M
2
NOC icon
Northrop Grumman
NOC
+$112M
3
HON icon
Honeywell
HON
+$98.1M
4
LIN icon
Linde
LIN
+$87M
5
UBER icon
Uber
UBER
+$72.9M

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Healthcare 16.16%
3 Financials 10.71%
4 Consumer Discretionary 9.79%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRO icon
1476
Sutro Biopharma
STRO
$423M
-1,100
Closed -$201K
TCRT icon
1477
Alaunos Therapeutics
TCRT
$4.84M
-467
Closed -$133K
TDS icon
1478
Telephone and Data Systems
TDS
$3.88B
-2,204
Closed -$44K
TIGR
1479
UP Fintech Holding
TIGR
$877M
-4,827
Closed -$50K
TPIC
1480
DELISTED
TPI Composites
TPIC
-2,350
Closed -$78K
TPL icon
1481
Texas Pacific Land
TPL
$24.2B
-1,962
Closed -$270K
TXMD icon
1482
TherapeuticsMD
TXMD
$24M
-1,390
Closed -$50K
UBX
1483
DELISTED
Unity Biotechnology
UBX
-1,300
Closed -$37K
UNFI icon
1484
United Natural Foods
UNFI
$2.8B
-2,123
Closed -$109K
URGN icon
1485
UroGen Pharma
URGN
$2.26B
-7,700
Closed -$128K
VMEO
1486
DELISTED
Vimeo
VMEO
-2,667
Closed -$79K
WIT icon
1487
Wipro
WIT
$19.7B
-27,094
Closed -$119K
WSBF icon
1488
Waterstone Financial
WSBF
$370M
-23,097
Closed -$477K
WVE icon
1489
Wave Life Sciences
WVE
$1.2B
-27,450
Closed -$128K
XBIT icon
1490
XBiotech
XBIT
$69.5M
-8,500
Closed -$110K
ZD icon
1491
Ziff Davis
ZD
$2B
-13,110
Closed -$1.61M
QTTB icon
1492
Q32 Bio
QTTB
$466M
-2,139
Closed -$292K
TECX
1493
Tectonic Therapeutic
TECX
$639M
-5,917
Closed -$394K
TVRD
1494
Tvardi Therapeutics
TVRD
$22M
-450
Closed -$246K
PSTX
1495
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-22,000
Closed -$154K
EGRX
1496
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-6,900
Closed -$379K
GTHX
1497
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-46,900
Closed -$695K
VTRU
1498
DELISTED
Vitru Limited Common Shares
VTRU
-135,000
Closed -$2.16M
FUSN
1499
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-13,000
Closed -$105K
CBAY
1500
DELISTED
Cymabay Therapeutics
CBAY
-24,000
Closed -$85K

Similar funds

DekaBank Deutsche Girozentrale's Q4 2021 Portfolio in Review

As of Q4 2021, DekaBank Deutsche Girozentrale held 1,526 positions worth $41.1B, up 15% from $35.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

DekaBank Deutsche Girozentrale deployed $2.44B of net new capital in Q4 2021, opening 158 new positions and adding to 755 existing holdings. Its largest new stake was Regal Rexnord: 103,299 shares worth $17.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Visa, an estimated $150M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q4 2021 buy was Regal Rexnord: 103,299 shares worth $17.6M.
  • DekaBank Deutsche Girozentrale added most to Mastercard in Q4 2021, an estimated $170M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2021 reduction was Visa, cutting an estimated $150M.
  • DekaBank Deutsche Girozentrale fully exited Kansas City Southern in Q4 2021, selling an estimated $20.2M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $41.1B portfolio in Q4 2021.
  • DekaBank Deutsche Girozentrale opened 158 new positions and closed 110 in Q4 2021.
  • DekaBank Deutsche Girozentrale's portfolio value rose 15% quarter-over-quarter to $41.1B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.